Search research articles
Contact Us
Filters
Showing results (271-280 of 395) with videos related to
Page
of 40
Sort By:
Environmental and Molecular Mutagenesis
|
October 6, 2005
A multi-biomarker analysis of DNA damage in automobile painters
A Testa, F Festa, R Ranaldi, et al.
Anti-Cancer Drugs
|
January 22, 1998
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM)
V Gebbia, N Borsellino, A Testa, et al.
Pediatrics
|
December 5, 2003
Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model
Shu-Chiung Chou, R Heather Palmer, Sudhakar Ezhuthachan, et al.
American Journal of Clinical Oncology
|
August 1, 1995
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck
V Gebbia, A Testa, C Di Gregorio, et al.
Oncology Reports
|
May 20, 2011
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome
A Testa, V Gebbia, N Borsellino, et al.
Cancer
|
September 15, 1996
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
V Gebbia, E Majello, A Testa, et al.
The Journal of Rheumatology
|
February 9, 2008
The risk of hospitalized infection in patients with rheumatoid arthritis
Allison L Smitten, Hyon K Choi, Marc C Hochberg, et al.
Cancer
|
September 16, 2006
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies
David J Straus, Marcia A Testa, Brenda J Sarokhan, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule
V Gebbia, R Valenza, A Testa, et al.
Bioelectromagnetics
|
December 30, 2003
Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses
L Stronati, A Testa, P Villani, et al.
Page
of 40
Search research articles
Search
Showing results (271-280 of 395) with videos related to
Sort By:
Page
of 40
Environmental and Molecular Mutagenesis
|
October 6, 2005
A multi-biomarker analysis of DNA damage in automobile painters
A Testa, F Festa, R Ranaldi, et al.
Anti-Cancer Drugs
|
January 22, 1998
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM)
V Gebbia, N Borsellino, A Testa, et al.
Pediatrics
|
December 5, 2003
Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model
Shu-Chiung Chou, R Heather Palmer, Sudhakar Ezhuthachan, et al.
American Journal of Clinical Oncology
|
August 1, 1995
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck
V Gebbia, A Testa, C Di Gregorio, et al.
Oncology Reports
|
May 20, 2011
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome
A Testa, V Gebbia, N Borsellino, et al.
Cancer
|
September 15, 1996
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
V Gebbia, E Majello, A Testa, et al.
The Journal of Rheumatology
|
February 9, 2008
The risk of hospitalized infection in patients with rheumatoid arthritis
Allison L Smitten, Hyon K Choi, Marc C Hochberg, et al.
Cancer
|
September 16, 2006
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies
David J Straus, Marcia A Testa, Brenda J Sarokhan, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule
V Gebbia, R Valenza, A Testa, et al.
Bioelectromagnetics
|
December 30, 2003
Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses
L Stronati, A Testa, P Villani, et al.
Page
of 40